Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents

Brain Res Bull. 2003 Jan 30;59(5):371-81. doi: 10.1016/s0361-9230(02)00930-9.

Abstract

Male Long-Evans rats sustained injections of 5,7-dihydroxytryptamine (5,7-DHT) into the fimbria-fornix and the cingular bundle or/and intraseptal injections of 192 IgG-saporin to induce serotonergic or/and cholinergic hippocampal denervations; Sham-operated rats served as controls. Four to ten weeks after lesioning, we measured (i). the electrically evoked release of acetylcholine ([3H]ACh), noradrenaline ([3H]NA) and serotonin ([3H]5-HT) in hippocampal slices in the presence of drugs acting on auto- or heteroreceptors, (ii). the nicotine-evoked release of NA and (iii). the choline acetyltransferase (ChAT) activity and the concentration of monoamines in homogenates. Saporin lesions reduced the accumulation of [3H]choline, the release of [3H]ACh and the ChAT activity, but increased the concentration of NA and facilitated the release of [3H]NA evoked by nicotine. 5,7-DHT lesions reduced the accumulation and the release of [3H]5-HT, the concentration of 5-HT, and also facilitated the release of [3H]NA evoked by nicotine. Accumulation and electrically evoked release of [3H]NA were not altered by either lesion. The combination of both toxins resulted in an addition of their particular effects. The 5-HT(1B) receptor agonist, CP 93129, and the muscarinic agonist, oxotremorine, reduced the release of [3H]ACh in control and 5,7-DHT-lesioned rats; in rats injected with saporin, their effects could not be measured reliably. CP 93129 and the alpha(2)-adrenoceptor agonist, UK 14304, reduced the release of [3H]5-HT in all groups by about 65%.

In conclusion: (i). selective neurotoxins can be combined to enable controlled and selective damage of hippocampal transmitter systems; (ii). 5-HT exerts an inhibitory influence on the nicotine-evoked release of NA, but partial serotonergic lesions do not influence the release of ACh at a presynaptic level and (iii). presynaptic modulatory mechanisms involving auto- and heteroreceptors may be conserved on fibres spared by the lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5,7-Dihydroxytryptamine / pharmacology
  • Acetylcholine / metabolism
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Biogenic Monoamines / analysis
  • Biogenic Monoamines / metabolism*
  • Brimonidine Tartrate
  • Choline O-Acetyltransferase / metabolism
  • Cholinergic Agents / pharmacology
  • Cholinergic Fibers / drug effects*
  • Cholinergic Fibers / metabolism
  • Electric Stimulation
  • Hippocampus / chemistry
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Immunotoxins / pharmacology
  • Male
  • N-Glycosyl Hydrolases
  • Neurons, Afferent / drug effects*
  • Neurons, Afferent / metabolism
  • Neurotoxins / pharmacology*
  • Nicotine / pharmacology
  • Nicotinic Agonists / pharmacology
  • Norepinephrine / metabolism
  • Organ Culture Techniques
  • Pyridines / pharmacology
  • Pyrroles / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Long-Evans
  • Ribosome Inactivating Proteins, Type 1
  • Saporins
  • Serotonin / metabolism
  • Serotonin Agents / pharmacology
  • Serotonin Receptor Agonists / pharmacology

Substances

  • 192 IgG-saporin
  • Adrenergic alpha-Agonists
  • Antibodies, Monoclonal
  • Biogenic Monoamines
  • Cholinergic Agents
  • Immunotoxins
  • Neurotoxins
  • Nicotinic Agonists
  • Pyridines
  • Pyrroles
  • Quinoxalines
  • Ribosome Inactivating Proteins, Type 1
  • Serotonin Agents
  • Serotonin Receptor Agonists
  • 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one
  • 5,7-Dihydroxytryptamine
  • Serotonin
  • Brimonidine Tartrate
  • Nicotine
  • Choline O-Acetyltransferase
  • N-Glycosyl Hydrolases
  • Saporins
  • Acetylcholine
  • Norepinephrine